483 Jiangsu Baozong & Baoda Pharmachem Jun 2019

483 Jiangsu Baozong & Baoda Pharmachem Jun 2019

Joel Hustedt FDA$119.00 - Available Now

FDA investigators audited the Jiangsu Baozong & Baoda Pharmachem - Rugao, China facility and issued inspectional observations (via FDA 483) on 21 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jun 2019
  • Location: Rugao, China
  • FEI: 3009160668
Add To Cart